In one institution, 25% of Crohn's patients had abnormal SI findings on MRE/MRI. Majority without back pain, were female with intestinal complications. Abs#1306 #ACR21 @RheumNow https://t.co/z8Yvc98s67

• Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease…

Young patients with #SLE #lupus have a #multimorbidity burden similar to individuals 30years older than them. A high #comorbidity burden is present in SLE pts of all ages compared to non-SLE. How can we address this? Abs#1049 #ACR21 #ACRBest @RheumNow https://t.co/U6t8YBFUZz https://t.co/v7Fwof1gZc

• Multimorbidity Differences Between Systemic Lupus Erythematosus Patients and Co…

#ACR21 Abs#1210: Frequency of anterior atlanto-axial sublux in RA ⭐️Anterior atlanto-axial subluxation (aAAS) = 3+ mm, frequency = 25% ⭐️Radicular pain 20%, surgery 6% ▶️Longer disease duration, ⬆️ frequency of extra-articular manifestations https://t.co/BfjCTlRJbt @Rheumnow https://t.co/xd9h5e9cDH

• https://bit.ly/3GUrrF4

Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumNow https://t.co/kTrR7I3HA0

Psoriasis can be diagnosed at any time of axSpA follow up. Incidence of PsO ⬆️from 16.8% to 26.8% after 6 years Patients with PsO had more peripheral arthritis and higher BMI Abs#1311 @RheumNow https://t.co/IrvHiFqr2m https://t.co/lqCVcF81zA

• De Novo Psoriasis Can Be Reported at Any Timepoint in Early Axial Spondyloarthr…

#clinicalpearls Cervical involvement in RA: is it underestimated? Cohort of 240pts: anterior atlantoaxial subluxation (aAAS) found in n=25 10.4 % patients, 1/3 with no neck pain! Joint restriction OR: 5.8 hx arthroplasty OR:3.6 #Abst1211 #ACR21 @RheumNow https://t.co/KRkDP4ETMu https://t.co/soKTMPiMwy

• Evaluation of the Cervical Involvement Frequency and Associated Risk Factors in…

#RA pts on #baricitinib less likely to discontinue treatment & more likely to achieve remission than pts receiving biologic /other tsDMARD. 👉🏼Results from RA-BE-REAL observational study 👉🏼Bari(2 or 4mg) vs biologic/other tsDMARD Abs#1223 #ACR21 @RheumNow https://t.co/WRN1OCX9Bq https://t.co/UCFF6hAY7G

• A Multinational, Prospective, Observational Study in Patients with Rheumatoid A…

In 🇦🇺 we're delighted to be working with @Sarah_L_Mackie et al on the STERLING-PMR trial: - relapsing PMR - pragmatic RCT - MTX (alt LEF) 🇬🇧 @NIHRresearch @LeedsBRC @profbdasgupta @DrMaxYates1 et al 🇦🇺 @nhmrc @CatherineL_Hill @helenkeen73 @drceowen #ACR21 PMR/GCA SG @RheumNow https://t.co/YtnPpHxNqz

Peripheral and axSpA pts with low Vitamin D levels (<30) had worse disease activity and functional impairment (BASDAI, ASDAS, BASFI) compared to pts with normal Vit D levels. Abs#1316 #ACR21 @RheumNow https://t.co/ulIqOAnWtp https://t.co/aMQaTpduJK

• Vitamin D Deficiency and Disease Activity in Patients with Spondyloarthritis - …

@Sineadm15 @bososhea on undiagnosed depression in axSpA. Common, and associated with worse disease activity and quality of life. Abstr#1305 #ACR21 @RheumNow https://t.co/PBH1F3XEGv

#ACR21 Abs#1224. ⬇️ CD39 expression on B cell predicts occurrence of anti-drug Ab in RA on RTX ⭐️13/23 pts on RTX became ADAb+. No diff in concomitant MTX usage ⭐️Baseline CD73 similar, but lower CD39 predictive of ADAb https://t.co/QzbAmXtTmZ @Rheumnow https://t.co/CLtEev69YD

• https://bit.ly/2YpkRVG

Minimal disease activity achievement in PsA achieved by 22.8% in 6 mo of b/ts DMARD MDA achievers were: ➡️Younger ➡️🔽 Disease duration; ➡️ Male ➡️Non-obese ➡️bDMARD-naïve at baseline ➡️🔼 probability achieving MDA components➕MCID PROMs at 6 mo Abst# 1344 #ACR21 @Rheumnow

Effect of BMI on PRO treatment response in PsA. Increasing BMI associated with lower response. More pronounced in TNFi than IL-17 or JAKi. Abstr#1327 #ACR21 @RheumNow https://t.co/qhgVlW72uM

In this study, ⭕AS pts w/>=2 #comorbidities were associated w/ poorer outcome measures after 2 yrs of ffup vs. pts w/ no comorbids ⭕Pts w/ >=2 comorbids were likely to dc 1st anti-TNF Address comorbidities, ⬆ chances of better outcomes & QoL @RheumNow #ACR21 abs1309 https://t.co/sTnjaC1a1l

#ACR21 Abs#1225: B/L Extracell Matrix Biomarkers predict ABA response in MTX-naive, +ACPA early RA ⭐️ECM biomarkers predict SDAI remission or DAS28 w ABA+MTX vs PBO+MTX. ⭐️⬆️CTX1 biomarker predicts efficacy endpts for ABA+MTX https://t.co/7wHQefb5D4 @Rheumnow

• https://bit.ly/31wNLV2